The gambling industry is increasingly involved in the funding of research on gambling disorder and responsible gambling. However, some critics have argued that industry funding might influence the research process. In response, researchers have begun to embrace “Open Science” practices (e.g., pre-registration of research questions and hypotheses, open access to materials and data) to foster transparency and create a valid, reliable, and replicable scientific literature. The panel will explore how Open Science principles and practices can be integrated with existing guidelines for industry-funded research to ensure that the research process is ethical, transparent, and unbiased.
Panel: Debi LaPlante, PhD, Harvard Medical School